Indian coup for Clonmel drug company

TIPPERARY-based pharmaceutical manufacturer Clonmel Healthcare has completed the sale of two drugs from its portfolio to the Indian skin and respiratory drug specialist Glenmark.

Indian coup for Clonmel drug company

Glenmark said the drugs, which it did not name, had a potential market in the United States worth €40 million.

Both drugs have been granted approval by American drug authorities.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited